Prague, Czechia

Petra Brehova

This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignee: Institute of Organic Chemistry and Biochemistry. Active years: 2023-2025.

USPTO Granted Patents = 2 

% Patents Active = 100.0


 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Petra Brehova: Innovator in Pharmaceutical Chemistry

Introduction

Petra Brehova is a prominent inventor based in Prague, Czech Republic. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. With a focus on modulating the STING protein, her work has the potential to impact the treatment of various diseases.

Latest Patents

Petra Brehova holds 2 patents that showcase her innovative research. The first patent is titled "2'3′-cyclic dinucleotides and prodrugs thereof." This patent relates to 2'3′ cyclic phosphonate dinucleotides, including their pharmaceutically acceptable salts and compositions. These compounds are designed for the treatment or prevention of diseases modifiable by STING protein modulation, such as cancer and viral, allergic, and inflammatory diseases. The second patent is "3'3′-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide as STING modulator." This patent focuses on 3'3′-cyclic dinucleotides that can modulate the activity of the STING adaptor protein, offering new avenues for therapeutic intervention.

Career Highlights

Petra Brehova is affiliated with the Institute of Organic Chemistry and Biochemistry, ASCR, v.v.i. Her work at this esteemed institution has allowed her to explore innovative solutions in pharmaceutical chemistry. She has dedicated her career to advancing the understanding of nucleotide analogues and their applications in medicine.

Collaborations

Throughout her career, Petra has collaborated with notable colleagues, including Gabriel Birkus and Ondrej Pav. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.

Conclusion

Petra Brehova's contributions to pharmaceutical chemistry through her patents and research are noteworthy. Her innovative work in modulating the STING protein holds promise for the future of medical treatments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…